A Case of Verruca Vulgaris Treated with Etretinate ( Tigason R ) / 대한피부과학회지
Korean Journal of Dermatology
; : 572-576, 1989.
Article
en Ko
| WPRIM
| ID: wpr-224971
Biblioteca responsable:
WPRO
ABSTRACT
Etretinate is a synthetic retinoic acid which has been reported effective in hyperkeratotic disorders. Recently, it has also been tried, on a limited number, for the treatment of viral wart. A 33-year-old male patient presented with multiple, tender, confluent, verrucous lesions on the scalp, both hands and feet of 4 years duration. Before coming to us, he had been treated with intralesional injection of bleomycin and electrodesiccation with little effect. We started etretinate therapy in a daily dose of 70mg(1mg /kg). After 3 weeks treatment, most of his skin lesions were flattened and softened: but an abrupt elevation of serum aminotransferases was noticed, which was normalized soon after cessation of medication. Unfortunately, the drug stop page aggravated most of skin lesions. After two weeks of withdrawal we started again the drug in a daily dose of 30mg and observed a good response without hepatic dysfunction.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Cuero Cabelludo
/
Piel
/
Tretinoina
/
Bleomicina
/
Verrugas
/
Etretinato
/
Inyecciones Intralesiones
/
Acitretina
/
Pie
/
Mano
Límite:
Adult
/
Humans
/
Male
Idioma:
Ko
Revista:
Korean Journal of Dermatology
Año:
1989
Tipo del documento:
Article